Wednesday
October 29
- From Missed Risk to Measurable Impact: Scaling Cancer Risk Identification Across the Health System 8:00 AM – 9:00 AM
• Advance from reactive to proactive care with accessible, system-wide high-risk patient identification
• Standardize guideline-based risk assessments for hereditary cancer testing and breast cancer risk to enable more equitable access to early diagnosis and prevention
• Discuss real-world barriers and strategies for scaling high-risk cancer identification programs
![overlay-bottom[1]](https://ambrygen.com/wp-content/uploads/2026/02/overlay-bottom1.svg)